[go: up one dir, main page]

AR025659A1 - USE OF A COMBINATION OF A BIORESPUEST MODIFIER AND A CHEMOTHERAPEUTIC AGENT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO POWER CHEMOTHERAPY AND TREAT SOLID TUMORS - Google Patents

USE OF A COMBINATION OF A BIORESPUEST MODIFIER AND A CHEMOTHERAPEUTIC AGENT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO POWER CHEMOTHERAPY AND TREAT SOLID TUMORS

Info

Publication number
AR025659A1
AR025659A1 ARP000104818A ARP000104818A AR025659A1 AR 025659 A1 AR025659 A1 AR 025659A1 AR P000104818 A ARP000104818 A AR P000104818A AR P000104818 A ARP000104818 A AR P000104818A AR 025659 A1 AR025659 A1 AR 025659A1
Authority
AR
Argentina
Prior art keywords
modifier
combination
chemotherapeutic agent
manufacture
biorespuest
Prior art date
Application number
ARP000104818A
Other languages
Spanish (es)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR025659A1 publication Critical patent/AR025659A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se provee uso de una combinacion de un modificador de biorespuesta y un agente quimioterapéutico para la manufactura de un medicamento para tratar tumoressolidos administrando una cantidad eficaz de una combinacion de (1) un modificador debiorespues ta y (2) un agente quimioterapéutico. También provee el uso deun modificador de biorespuesta de más de un régimen quimioterapéutico para potenciar los efectos de un régimen quimioterapéutico en un mamífero que necesita dedicho tratamientocon dicho r égimen que comprende administrar un modificador de biorespuesta además de un régimen quimioterapéutico.Use is made of a combination of a bio-response modifier and a chemotherapeutic agent for the manufacture of a medicament for treating tumor tumors by administering an effective amount of a combination of (1) a post-modifier and (2) a chemotherapeutic agent. It also provides the use of a bioresponing modifier of more than one chemotherapeutic regimen to potentiate the effects of a chemotherapeutic regimen in a mammal that needs such treatment with said regimen comprising administering a biosponder modifier in addition to a chemotherapeutic regimen.

ARP000104818A 1999-09-15 2000-09-14 USE OF A COMBINATION OF A BIORESPUEST MODIFIER AND A CHEMOTHERAPEUTIC AGENT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO POWER CHEMOTHERAPY AND TREAT SOLID TUMORS AR025659A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39605199A 1999-09-15 1999-09-15

Publications (1)

Publication Number Publication Date
AR025659A1 true AR025659A1 (en) 2002-12-11

Family

ID=23565645

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104818A AR025659A1 (en) 1999-09-15 2000-09-14 USE OF A COMBINATION OF A BIORESPUEST MODIFIER AND A CHEMOTHERAPEUTIC AGENT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO POWER CHEMOTHERAPY AND TREAT SOLID TUMORS

Country Status (8)

Country Link
EP (1) EP1214092A2 (en)
JP (1) JP2003509383A (en)
CN (1) CN1391484A (en)
AR (1) AR025659A1 (en)
AU (1) AU7373600A (en)
BR (1) BR0014001A (en)
CA (1) CA2381078A1 (en)
WO (1) WO2001019399A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL392652A1 (en) * 2001-05-16 2010-12-06 Novartis Ag A combination consisting of N-{5-[4-(4-methyl-piperazine-methyl)-benzoiloamido]-2-methylphenyl} -4-(3-pyridyl)-2-pyrimidine-amine and the chemotherapeutic agent, the use thereof, pharmaceutical composition containing thereof a kit containing such a combination
CN109601739B (en) * 2019-01-17 2022-10-14 河南湾流生物科技有限公司 A kind of compound amino acid feed additive and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056770A1 (en) * 1998-02-24 2000-12-06 Dovetail Technologies, Inc. Novel disulfides and thiol compounds
JP2002533404A (en) * 1998-12-23 2002-10-08 ジー・ディー・サール・アンド・カンパニー Methods of using integrin antagonists and radiation therapy as combination therapy in the treatment of neoplasia

Also Published As

Publication number Publication date
CA2381078A1 (en) 2001-03-22
AU7373600A (en) 2001-04-17
WO2001019399A3 (en) 2001-12-13
EP1214092A2 (en) 2002-06-19
WO2001019399A2 (en) 2001-03-22
BR0014001A (en) 2002-05-21
JP2003509383A (en) 2003-03-11
CN1391484A (en) 2003-01-15

Similar Documents

Publication Publication Date Title
BR0307975A (en) Methods for chronically reducing pathological inflammation in a patient and for determining the effectiveness of a chronic administration regimen for treating pathological inflammation in an individual, composition and combined therapy for chronic treatment of pathological inflammation in a patient and use of an alpha inhibitor. 4-integrin
BRPI0207961B8 (en) use of epothilone and capecitabine analogues to manufacture medicine to treat solid cancerous tumors and kit comprising said compounds.
BR0009213A (en) Processes and compositions for the treatment of solid tumors
ES2156839T1 (en) MEDICINAL CONTAINING ALGINATE AND IMPLANT TO TREAT FIBROSIS.
BR0115162A (en) Effective antitumor treatments
AR023806A1 (en) USE OF A PEPTIDE MIXTURE FOR THE MANUFACTURE OF A THERAPEUTIC AGENT FOR PROFILAXIS AND / OR CANCER TREATMENT, PHARMACEUTICAL COMPOSITIONS AND VACCINES CONTAINING SUCH MIXTURE AND THE PROCEDURES FOR PREPARATION OF THESE COMPOSITIONS
ES2062155T3 (en) COMPOSITIONS FOR THE TREATMENT OF NEOPLASIA CONTAINING AN ANTINEOPLASTIC AGENT AND A PROTECTIVE AGENT REDUCING SIDE EFFECTS.
MX9305934A (en) NEW MULTIPLE DRUG RESISTANCE MODIFIER.
AR041023A1 (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING ANTIBODY IMMUNOCATE PLAYERS FOR CD44 CYTOTOXICS AND CHEMOTHERAPEUTIC AGENTS
AR012172A2 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING ANALOGS OF LACTACISTIN AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AR034900A1 (en) USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT
ES2144119T3 (en) USE OF NON-STEROID CYCLOOXYGENASE INHIBITORS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HIGH INTRAOCULAR PRESSURE.
CR7575A (en) USE OF DOCETAXEL / DOXORRUBICIN / CYCLOPHOSPHAMIDE IN THE ADJUSING THERAPY OF CANCER OF BREAST AND OVARY
KR960700063A (en) Potentiation of temozolomide in human tumour cells
BG106057A (en) Method of enhancing the efficacy of anti-tumour agents
CA2245890A1 (en) Use of an extract of cimicifuga racemosa
AR015744A1 (en) USE OF DEXMEDETOMIDINE FOR SEDATION IN INTENSIVE THERAPY
AR035946A1 (en) PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES
BRPI0518250A2 (en) anticancer treatments
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
BR0110150A (en) Method and composition for treating cancer by administering apoptosis-inducing chemotherapeutic agents
AR036321A1 (en) METHOD AND PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF LATE APPEARANCE DYSCINESIA.
GT200000194A (en) COMBINATION CHEMOTHERAPY.
AR025659A1 (en) USE OF A COMBINATION OF A BIORESPUEST MODIFIER AND A CHEMOTHERAPEUTIC AGENT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO POWER CHEMOTHERAPY AND TREAT SOLID TUMORS
AR034142A1 (en) A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION